Pharmacytimes: Condition Center: Pain Management Pain Management en-us Mon, 25 Jun 2018 02:06:17 UTC Mon, 25 Jun 2018 02:06:17 UTC Despite Increased Access, Naloxone Prescription Rates Low in Study Researchers were not able to predict factors that would indicate that pharmacists actually dispense the medication.<br /> &nbsp; 3:22 PM, Tue June 19, 2018 Are Nutraceuticals the Answer for Patients with Chronic Conditions? During a presentation at the American Pharmacy Purchasing Alliance&#39;s Pharmacon in Orlando, FL, several panelists discussed the use of nutraceuticals in managing conditions like chronic pain. 8:20 PM, Sat June 9, 2018 Glove and Stocking Pain: Hallmark of Peripheral Neuropathy Half of people who have diabetes eventually develop diabetic peripheral neuropathy, and the warning signs are sensory symptoms that start in the distant periphery and progressing in a characteristic &#39;glove and stocking&#39; way. 12:25 PM, Thu June 7, 2018 FDA Officials Issue Warning Letters to 3 Kratom Marketers Health care professionals and consumers are encouraged to report any adverse events related to these products to the FDA&rsquo;s&nbsp;MedWatch&nbsp;Adverse Event Reporting program. 9:55 PM, Tue May 22, 2018 FDA Approves Preventive Migraine Treatment Erenumab-aooe (Aimovig, Amgen) is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of the molecule that is involved in migraine attacks. 6:00 PM, Thu May 17, 2018 FDA Approves First Non-opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults The FDA has approved lofexidine hydrochloride (Lucemyra) for the mitigation of opioid withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults. 5:57 PM, Wed May 16, 2018 Neuropathic Pain: A Glimpse Inside the Unabating Affliction Originating from damage within nerve cells themselves, neuropathic pain is often complex, with many treatment challenges. 9:00 AM, Tue March 20, 2018 Best Practices in Transforming Chronic Pain Care The number of opioids prescribed in the Untied States was approximately 3 times as high in 2015 as it was in 1999. 12:00 PM, Sun March 11, 2018 FDA OKs Non-Opioid Pain Patch for Post-Herpetic Neuralgia The FDA approved ZTlido (lidocaine topical system) 1.8% for the treatment of pain associated with post-herpetic neuralgia (PHA), which is caused by shingles. 4:37 PM, Wed February 28, 2018 FDA Approves Short-Term Acute Pain Management Drug Kempharma introduces newly approved pain management drug and warns of risk for addiction. 8:00 AM, Sat February 24, 2018 Surgeons Play Key Role in Reducing Post-Surgery Opioid Dependency One in 7 patients who have had lung surgery become persistent opioid users, data note.<br /> <br /> &nbsp; 11:20 AM, Wed February 7, 2018 Opinion: A Reaction to DEA's Efforts to Target Pharmacies with 'Unusual' Opioid Prescription Rates Although it is unclear what constitutes “unusual or disproportionate,” such phrases are particularly disturbing when we realize that the regulation of medical practice is a traditional state function, not a federal one. 2:56 AM, Mon February 5, 2018 The Benefits of Integrating Pharmacists into Surgical Patient Education Surgical patients can exhibit anxiety about the medications they will be started on following surgery. Pharmacists are in a position to address those concerns to the benefit of all. 9:00 AM, Wed January 31, 2018 Migraine Headache: A Look at Current Treatments and the Pipeline Migraine is a condition characterized mainly by severe and recurrent headaches. Approximately 12% of the general population experiences migraines, with a higher frequency in women than men. 1:00 PM, Tue January 30, 2018 Pharmacists' Role in the Management of Perioperative Analgesia More than 75% of patients who undergo surgery experience moderate to severe acute postoperative pain that begins immediately following surgery and may extend beyond hospital discharge. 7:00 AM, Wed January 24, 2018 Opioid Agonists, Partial Agonists, Antagonists: Oh My! A look at the different receptor bindings that affect analgesic effect. 8:00 AM, Sat January 6, 2018 Digital Pills Track Patient Dosing and Combat Opioid Addiction Those familiar with the technology hope that the concept will develop enough that it can be integrated into daily life, as with an Apple Watch or a smartphone. 10:08 PM, Tue January 2, 2018 Sublocade for Opioid Use Disorder: What Pharmacists Should Know This article highlights several key therapeutics areas with Sublocade that every pharmacist should know. 11:01 PM, Mon January 1, 2018 Appropriate Gabapentin Dosing for Neuropathic Pain The established therapeutic dosing for gabapentin in neuropathic pain is 1800-3600 mg/day in 3 divided doses in patients with normal renal function. 10:09 PM, Tue December 19, 2017 Fosfomycin Use Fosfomycin (Monurol) is an antibiotic that uses a unique mechanism of action to establish its bactericidal activity. 5:00 PM, Thu November 30, 2017